SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avadel AVDL
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sammaster who wrote (206)10/24/2007 9:32:25 AM
From: sammaster   of 240
 
i got pretty close with simplistic calculations..

gsk states 31mil pounds= @ 62 million dollars of coreg cr sales

my guess for next quarter based on current run rate
for coreg cr of about 45k scripts= $75million

im sure the launch of coreg generic was brutal but hopefully the furhter we get out from that the more slaes will pick up, so about revenue target could go up

lets see what gsk says in their CC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News